Literature DB >> 19762088

L-epinephrine and dexamethasone in postextubation airway obstruction: a prospective, randomized, double-blind placebo-controlled study.

Regina Grigolli Cesar1, Werther Brunow de Carvalho.   

Abstract

PURPOSE: This prospective randomized double-blind placebo-controlled study paired trial groups to investigate the effect of intravenous dexamethasone and nebulized L-epinephrine on the clinical development of postextubation laryngeal edema.
MATERIAL AND METHODS: Sixty-four patients aged 1 day to 12 years who needed intubation from August/1997 to February/1999 in the Pediatric Intensive Care Unit (PICU) of Santa Casa de São Paulo School of Medicine were paired according to age, height and weight, anthropometric z-scores, duration of tracheal intubation and number of intubation attempts. Patients received intravenous dexamethasone (0.2mg/kg every 6h), with or without nebulized L-epinephrine (0.5mg/kg every 4h) in the study groups; in the control groups, they received nebulized or intravenous isotonic saline solution, or both. DEPENDENT VARIABLES: frequency and severity of the laryngeal edema (according to Westley Clinical Scoring System), as well as the time interval (min) between extubation and the first postextubation laryngeal edema scores. Postextubation respiratory rate and transcutaneous oxygen saturation were employed as indicators of the clinical conditions for extubation.
RESULTS: Laryngeal edema frequencies did not change according to treatments, chi(2) (3, N=64)=0.58, p>0.05, and the highest scores were not reached in the 24h after extubation, chi(ranks)(2) (3, N=16)=1.03, p>0.05.
CONCLUSIONS: Dexamethasone and l-epinephrine did not reduce the clinical progression of airway obstruction due to laryngeal edema in the early postextubation period.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19762088     DOI: 10.1016/j.ijporl.2009.08.004

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  6 in total

1.  Nebulized 0.5, 2.5 and 5 ml L-epinephrine for post-extubation stridor in children: a prospective, randomized, double-blind clinical trial.

Authors:  Paulo Sérgio Lucas da Silva; Marcelo Cunio Machado Fonseca; Simone Brasil Oliveira Iglesias; Emílio Lopes Junior; Vânia Euzébio de Aguiar; Werther Brunow de Carvalho
Journal:  Intensive Care Med       Date:  2011-11-26       Impact factor: 17.440

2.  Use of Dexamethasone to Prevent Extubation Failure in Pediatric Intensive Care Unit: A Randomized Controlled Clinical Trial.

Authors:  Haroldo Teófilo de Carvalho; José Roberto Fioretto; Rossano Cesar Bonatto; Cristiane Franco Ribeiro; Joelma Gonçalves Martin; Mário Ferreira Carpi
Journal:  J Pediatr Intensive Care       Date:  2020-11-03

3.  Scientific rationale for the use of alpha-adrenergic agonists and glucocorticoids in the therapy of pediatric stridor.

Authors:  Gustavo Nino; Orkun Baloglu; Maria J Gutierrez; Michael Schwartz
Journal:  Int J Otolaryngol       Date:  2011-12-19

Review 4.  Postextubation laryngeal edema and stridor resulting in respiratory failure in critically ill adult patients: updated review.

Authors:  Wouter A Pluijms; Walther Nka van Mook; Bastiaan Hj Wittekamp; Dennis Cjj Bergmans
Journal:  Crit Care       Date:  2015-09-23       Impact factor: 9.097

Review 5.  Evidence and evidence gaps of medical treatment of non-tumorous diseases of the head and neck.

Authors:  Murat Bas
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2016-12-15

6.  Dexamethasone in Prevention of Postextubation Stridor in Ventilated Children: A Randomized, Double-blinded, Placebo-controlled Trial.

Authors:  Urmila Jhamb
Journal:  Indian J Crit Care Med       Date:  2020-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.